dr. lenz on later-line combo approaches in crc
Published 4 years ago • 126 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
2:24
dr. lenz on optimal sequencing strategies in crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
1:13
dr. lenz on breakthrough designation of encorafenib, binimetinib, and cetuximab in braf crc
-
0:53
dr. lenz on the safety profile of checkmate-142 trial in crc
-
8:36
precious lentis mplus, a lens rivaling a diamond (dr. alan koh, malaysia)
-
12:09
femtis - the perfect auto-cc iol (dr. jung wan kim (md) )
-
10:25
update on the toric implantable collamer lens
-
6:04
third-line treatment in refractory crc
-
8:51
dr. lenz's speech on advancements in curing colorectal cancer
-
1:00
dr. lenz on next steps with immunotherapy in mcrc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
7:00
sequencing considerations in mss crc tumors
-
2:04
dr. lenz on the changing landscape of metastatic colorectal cancer
-
5:06
the potential for combining checkpoint inhibitors
-
13:11
treatment sequencing in metastatic colorectal cancer
-
0:53
dr. lenz on potential for immunotherapy in mcrc
-
2:01
dr. mccollum on frontline therapy for patients with metastatic crc
-
3:13
endoscopic cervical rhizotomy - doris brengel's testimonial
-
1:03
dr. lenz on the updated findings from the checkmate-142 trial in mcrc
-
0:46
laparoscopic lightweight needle holders